Benoît Sanson
A5044415968- Muscle Physiology and Disorders
- Stroke Rehabilitation and Recovery
- Myasthenia Gravis and Thymoma
- Long-Term Effects of COVID-19
- Genetic Neurodegenerative Diseases
- Telemedicine and Telehealth Implementation
- Temporomandibular Joint Disorders
- Mitochondrial Function and Pathology
Centre Hospitalier Universitaire de Nice
2018-2022
Université Côte d'Azur
2018
Facioscapulohumeral muscular dystrophy is a rare inherited neuromuscular disease with an estimated prevalence of 1/20,000 and France therefore harbors about 3000 FSHD patients. With research progress the development targeted therapies, patients' identification through registries can facilitate improve recruitment in clinical trials studies. The French National Registry patients was designed as mixed model registry involving both physicians, self-report evaluation questionnaires respectively,...
Abstract Background Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent dystrophies and currently has no treatment. Clinical genetic heterogeneity are main challenges to a full comprehension of physiopathological mechanism. Improving our knowledge FSHD crucial development future therapeutic trials standards care. National registries have been set up this end. The French Registry combines clinical evaluation form (CEF) self-report questionnaire (SRQ), filled out by...
Telemedicine (TM) contributes to bridge the gap between healthcare facilities and patients' homes with neuromuscular disease (NMD) because of mobility issues. However, its deployment is limited due difficulties evaluating subtle neurological signs such as mild weakness or sensory deficits. The COVID-19 pandemic has disrupted delivery worldwide, necessitating rapid measures implementation by health care providers (HCPs) protect patients from acquiring SARS-CoV-2 while maintaining best...